Clinical Trial Update: AZD1656 in Diabetic Patients Hospitalised With Suspected or Confirmed COVID-19 [Phase 2]

View source ↗

Summary

Phase 2 trial results for AZD1656 in hospitalized diabetic patients with suspected or confirmed COVID-19 have been completed and results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• AZD1656

Snippet

Sponsor: St George Street Capital | Conditions: Covid19 | Phase 2 | Status: COMPLETED | Results posted: 2022-04-25